Financials MedCap AB

Equities

MCAP

SE0009160872

Investment Management & Fund Operators

Market Closed - Nasdaq Stockholm 11:29:44 2024-04-26 am EDT 5-day change 1st Jan Change
421.5 SEK +2.18% Intraday chart for MedCap AB +5.64% +24.89%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,068 1,870 3,403 2,636 3,206 4,997
Enterprise Value (EV) 1 1,213 2,174 3,520 2,753 3,310 5,070
P/E ratio 2,895 x 34.9 x 54.2 x 27.4 x 27.4 x 29.1 x
Yield - - - - - -
Capitalization / Revenue 1.51 x 2.47 x 4.15 x 2.84 x 2.85 x 3.12 x
EV / Revenue 1.71 x 2.87 x 4.3 x 2.97 x 2.94 x 3.17 x
EV / EBITDA 18.2 x 23.6 x 33.8 x 19.2 x 17.5 x 18.3 x
EV / FCF 17.2 x 64.9 x 43.5 x 124 x -235 x 23.8 x
FCF Yield 5.81% 1.54% 2.3% 0.81% -0.42% 4.2%
Price to Book 3.94 x 5.7 x 5.71 x 3.79 x 3.74 x 4.89 x
Nbr of stocks (in thousands) 13,451 13,451 14,796 14,807 14,807 14,807
Reference price 2 79.40 139.0 230.0 178.0 216.5 337.5
Announcement Date 4/16/19 4/17/20 3/29/21 3/28/22 3/28/23 3/27/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 709.3 757.4 819.6 928.2 1,124 1,600
EBITDA 1 66.6 92.3 104.3 143.1 188.6 277.8
EBIT 1 42 78.4 73 105.8 146.7 225.7
Operating Margin 5.92% 10.35% 8.91% 11.4% 13.05% 14.11%
Earnings before Tax (EBT) 1 40.3 72.2 81.5 117 152 222.3
Net income 1 0.6 53.7 60.9 96.5 117.6 172.2
Net margin 0.08% 7.09% 7.43% 10.4% 10.46% 10.76%
EPS 2 0.0274 3.988 4.243 6.500 7.900 11.60
Free Cash Flow 1 70.41 33.49 80.84 22.25 -14.06 212.7
FCF margin 9.93% 4.42% 9.86% 2.4% -1.25% 13.3%
FCF Conversion (EBITDA) 105.72% 36.28% 77.5% 15.55% - 76.57%
FCF Conversion (Net income) 11,735.42% 62.36% 132.74% 23.06% - 123.53%
Dividend per Share - - - - - -
Announcement Date 4/16/19 4/17/20 3/29/21 3/28/22 3/28/23 3/27/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 145 304 117 117 104 73
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.176 x 3.297 x 1.125 x 0.819 x 0.5504 x 0.2628 x
Free Cash Flow 1 70.4 33.5 80.8 22.3 -14.1 213
ROE (net income / shareholders' equity) 9.79% 19% 13.8% 15.1% 15.2% 18.3%
ROA (Net income/ Total Assets) 4.14% 6.67% 4.74% 5.88% 7.06% 9.13%
Assets 1 14.5 805.2 1,284 1,642 1,667 1,887
Book Value Per Share 2 20.20 24.40 40.30 47.00 57.80 69.10
Cash Flow per Share 2 4.210 1.530 9.900 9.430 16.00 12.70
Capex 1 14.6 12.1 11.3 45.3 26.3 22.1
Capex / Sales 2.06% 1.6% 1.38% 4.88% 2.34% 1.38%
Announcement Date 4/16/19 4/17/20 3/29/21 3/28/22 3/28/23 3/27/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA